Perspectives S35/Ep53 The Importance of a diverse patient population in clinical trials

There is simply not enough diversity among the patient population when it comes to clinical trials in health care. It's a problem that's been around for many decades. Morehouse School of Medicine is working to make a difference. The African American Heart Study is a collaboration between Amgen, the Association of Black Cardiologists (ABC) and the Morehouse School of Medicine. Dr. Elizabeth Ofili, a professor of medicine at MSM and practicing cardiologist joins me to explain the new research and discuss the goal of the studio - to measure the association between Lipoprotein(a), and atherosclerotic cardiovascular disease (ASCVD) in 5,000 African American individuals across the United States. ASCVD is defined as the buildup of cholesterol plaque in arteries and includes events such as heart attack and stroke.